GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall

MT Newswires Live

04/16

GeoVax Labs (GOVX) said late Monday Advanced Technology International notified the company to stop work on its phase 2b study to evaluate the GEO-CM04S1 COVID-19 vaccine.

Advanced Technology is the Rapid Response Partnership Vehicle's consortium management firm funded by the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services, according to its regulatory filing.

The notice indicated that BARDA decided to terminate the contract for convenience to the government, the filing said.

Shares of the company were down over 21% in Tuesday trading.

Price: 0.84, Change: -0.23, Percent Change: -21.50

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2527644764"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527644764\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2527644764?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-16 00:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527644764","market":"nz","top_or_hot":-1,"title":"GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall","media":"MT Newswires Live","content":"<html><body><p> GeoVax Labs (GOVX) said late Monday Advanced Technology International notified the company to stop work on its phase 2b study to evaluate the GEO-CM04S1 COVID-19 vaccine.</p><p>Advanced Technology is the Rapid Response Partnership Vehicle's consortium management firm funded by the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services, according to its regulatory filing.</p><p>The notice indicated that BARDA decided to terminate the contract for convenience to the government, the filing said.</p><p>Shares of the company were down over 21% in Tuesday trading.</p><p>Price: 0.84, Change: -0.23, Percent Change: -21.50</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-04-16 00:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> GeoVax Labs (GOVX) said late Monday Advanced Technology International notified the company to stop work on its phase 2b study to evaluate the GEO-CM04S1 COVID-19 vaccine.</p><p>Advanced Technology is the Rapid Response Partnership Vehicle's consortium management firm funded by the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services, according to its regulatory filing.</p><p>The notice indicated that BARDA decided to terminate the contract for convenience to the government, the filing said.</p><p>Shares of the company were down over 21% in Tuesday trading.</p><p>Price: 0.84, Change: -0.23, Percent Change: -21.50</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4583","symbol_name":"猴痘概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2527644764","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527644764","pubTimestamp":1744733524,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"GeoVax Labs  said late Monday Advanced Technology International notified the company to stop work on its phase 2b study to evaluate the GEO-CM04S1 COVID-19 vaccine.Advanced Technology is the Rapid Response Partnership Vehicle's consortium management firm funded by the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services, according to its regulatory filing.The notice indicated that BARDA decided to terminate the contract for convenience to the government, the filing said.Shares of the company were down over 21% in Tuesday trading.Price: 0.84, Change: -0.23, Percent Change: -21.50","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4583":"猴痘概念","GOVX":"GeoVax Labs Inc","BK4139":"生物科技","BNTX":"BioNTech SE"},"translate_title":"GeoVax的新冠肺炎疫苗研究被资助机构终止；股价下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GOVX":0.9,"BNTX":1},"content_text":"GeoVax Labs (GOVX) said late Monday Advanced Technology International notified the company to stop work on its phase 2b study to evaluate the GEO-CM04S1 COVID-19 vaccine.Advanced Technology is the Rapid Response Partnership Vehicle's consortium management firm funded by the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services, according to its regulatory filing.The notice indicated that BARDA decided to terminate the contract for convenience to the government, the filing said.Shares of the company were down over 21% in Tuesday trading.Price: 0.84, Change: -0.23, Percent Change: -21.50","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}